Focus Partners Advisor Solutions LLC Takes $1.05 Million Position in Cardinal Health, Inc. $CAH

Focus Partners Advisor Solutions LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAHFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 4,438 shares of the company’s stock, valued at approximately $1,054,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Cardinal Health in the fourth quarter valued at about $790,344,000. Wellington Management Group LLP raised its stake in Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Marshall Wace LLP raised its stake in Cardinal Health by 1,328.1% in the 4th quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after purchasing an additional 884,648 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Cardinal Health by 7,053.4% in the 1st quarter. Bessemer Group Inc. now owns 750,038 shares of the company’s stock valued at $158,491,000 after purchasing an additional 739,553 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after purchasing an additional 617,775 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Down 0.1%

NYSE CAH opened at $234.92 on Monday. The company has a market cap of $54.64 billion, a price-to-earnings ratio of 32.49, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a twelve month low of $145.87 and a twelve month high of $258.30. The business’s fifty day moving average is $230.30 and its 200 day moving average is $217.19.

Cardinal Health (NYSE:CAHGet Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same period last year, the company earned $2.08 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of analyst reports. Bank of America increased their price target on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Barclays upped their target price on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday. Citigroup increased their target price on Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. UBS Group raised their price target on Cardinal Health from $274.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Leerink Partners set a $292.00 price target on Cardinal Health in a research note on Tuesday, August 11th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $265.93.

View Our Latest Stock Analysis on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.